Cas no 100960-35-8 (5-Chloro-1H-indazol-6-amine)
5-Chloro-1H-indazol-6-amine Chemical and Physical Properties
Names and Identifiers
-
- 5-Chloro-1H-indazol-6-amine
- 6-AMINO-5-CHLORO-1H-INDAZOLE
- 5-Chloro-1H-indazol-6-ylamine
- 5-chloro-1(2)H-indazol-6-ylamine
- 1H-Indazol-6-amine, 5-chloro-
- 1h-indazol-6-amine,5-chloro-
- FCH1167252
- AK148050
- AX8285415
- CS-0157817
- 100960-35-8
- SCHEMBL7573724
- AKOS022187995
- DS-8829
- A910945
- C71050
-
- MDL: MFCD11846310
- Inchi: 1S/C7H6ClN3/c8-5-1-4-3-10-11-7(4)2-6(5)9/h1-3H,9H2,(H,10,11)
- InChI Key: UBSUVQXJCAJWPB-UHFFFAOYSA-N
- SMILES: ClC1=CC2C=NNC=2C=C1N
Computed Properties
- Exact Mass: 167.0250249g/mol
- Monoisotopic Mass: 167.0250249g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 153
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 54.7
- XLogP3: 1.5
Experimental Properties
- Boiling Point: 381.9±22.0°C at 760 mmHg
5-Chloro-1H-indazol-6-amine Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Storage Condition:Keep in dark place,Inert atmosphere,2-8°C
5-Chloro-1H-indazol-6-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBZ3727-500 MG |
5-chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 500MG |
¥ 2,560.00 | 2021-05-07 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBZ3727-1 G |
5-chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 1g |
¥ 3,201.00 | 2021-05-07 | |
| Alichem | A269001191-250mg |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 250mg |
$222.56 | 2023-09-04 | |
| Alichem | A269001191-1g |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 1g |
$525.20 | 2023-09-04 | |
| Ambeed | A276614-100mg |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95+% | 100mg |
$59.00 | 2021-07-14 | |
| Ambeed | A276614-250mg |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95+% | 250mg |
$118.00 | 2021-07-14 | |
| Ambeed | A276614-1g |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 1g |
$309.0 | 2024-04-26 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD269796-100mg |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 100mg |
¥439.0 | 2022-03-01 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD269796-250mg |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 250mg |
¥878.0 | 2022-03-01 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD269796-1g |
5-Chloro-1H-indazol-6-amine |
100960-35-8 | 95% | 1g |
¥2195.0 | 2022-03-01 |
5-Chloro-1H-indazol-6-amine Suppliers
5-Chloro-1H-indazol-6-amine Related Literature
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
-
J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
Additional information on 5-Chloro-1H-indazol-6-amine
Professional Introduction to 5-Chloro-1H-indazol-6-amine (CAS No. 100960-35-8)
5-Chloro-1H-indazol-6-amine, identified by its Chemical Abstracts Service (CAS) number 100960-35-8, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indazole class, characterized by a fused benzene and pyrrole ring system, which is a common structural motif in many biologically active molecules.
The< strong>5-Chloro substituent on the indazole ring introduces a region of electrophilic reactivity, making it a valuable intermediate in the synthesis of more complex molecules. The< strong>1H-indazol-6-amine moiety provides a nucleophilic site for further functionalization, enabling the construction of diverse pharmacophores. These properties have positioned 5-Chloro-1H-indazol-6-amine as a versatile building block in drug discovery and development.
In recent years, there has been growing interest in indazole derivatives due to their demonstrated pharmacological activities. Specifically, compounds within this class have shown promise in various therapeutic areas, including oncology, anti-inflammatory diseases, and central nervous system (CNS) disorders. The< strong>CAS no. 100960-35-8 identifier ensures precise chemical characterization and facilitates its use in both academic research and industrial applications.
One of the most compelling aspects of 5-Chloro-1H-indazol-6-amine is its role as a precursor in the synthesis of small-molecule inhibitors targeting specific biological pathways. For instance, studies have highlighted its utility in generating inhibitors of kinases and other enzymes implicated in cancer progression. The< strong>chloro group enhances reactivity, allowing for selective modifications that can fine-tune the pharmacokinetic and pharmacodynamic properties of the final drug candidates.
The indazole scaffold is particularly interesting because it can be readily modified to produce compounds with enhanced binding affinity and selectivity. Researchers have leveraged this flexibility to develop molecules that interact with proteins involved in cell signaling, transcriptional regulation, and metabolic pathways. These interactions are critical for modulating disease processes at the molecular level.
In the context of oncology research, 5-Chloro-1H-indazol-6-amine has been explored as a scaffold for developing novel chemotherapeutic agents. Its ability to undergo diverse chemical transformations has enabled the creation of derivatives with potent antitumor activity. Preclinical studies have demonstrated that certain indazole-based compounds can induce apoptosis in cancer cells while exhibiting minimal toxicity toward healthy tissues. This balance is crucial for developing effective and safe treatments.
The< strong>CAS no. 100960-35-8 registration provides a reliable reference point for researchers working with this compound, ensuring consistency across different studies and applications. This standardization is essential for reproducibility in scientific investigations and for regulatory compliance in drug development.
Beyond oncology, 5-Chloro-1H-indazol-6-amine has shown potential in addressing inflammatory conditions. Indazole derivatives have been found to modulate inflammatory pathways by inhibiting key enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX). These enzymes are central to the production of pro-inflammatory mediators like prostaglandins and leukotrienes. By targeting these pathways, indazole-based compounds may offer therapeutic benefits in chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
The central nervous system (CNS) is another area where indazole derivatives have demonstrated promise. Research indicates that certain indazole compounds can cross the blood-brain barrier and interact with neurotransmitter systems involved in mood regulation, cognition, and pain perception. This makes them attractive candidates for developing treatments for neurological disorders such as depression, anxiety disorders, and neuropathic pain.
The synthesis of< strong>5-Chloro-1H-indazol-6-amine< strong>CAS no 100960358< strong>CAS no 100960358indazole derivative pharmaceutical intermediates involves multi-step organic reactions that highlight its synthetic utility. Common synthetic routes include nucleophilic aromatic substitution reactions on halogenated indazoles or cyclization reactions involving appropriate precursors. These methods showcase the compound's versatility as a synthetic intermediate.
The growing body of research on indazole derivatives underscores their importance as pharmacological tools. Advances in computational chemistry and high-throughput screening techniques have accelerated the discovery process by allowing rapid evaluation of large libraries of indazole-based compounds. This synergy between experimental chemistry and computational methods has led to several promising candidates entering clinical trials.
In conclusion, 5-Chloro-1H-indazol-6-am ine (CAS No 100960358)< strong>CAS no 100960358indazole derivative pharmaceutical intermediates plays a pivotal role in modern drug discovery efforts across multiple therapeutic areas including oncology antiinflammatory diseases CNS disorders The compound's structural features functional versatility synthetic accessibility make it an invaluable asset for medicinal chemists seeking to develop novel therapeutic agents Addressing unmet medical needs requires innovative approaches such as those enabled by versatile intermediates like this one ensuring continued progress toward effective treatments for human diseases The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound The future holds exciting possibilities as researchers continue to explore new applications for this remarkable heterocyclic compound
100960-35-8 (5-Chloro-1H-indazol-6-amine) Related Products
- 864082-49-5(7-chloro-1H-Indazol-5-amine)
- 1211527-21-7(7-chloro-1h-indazol-4-amine)
- 825654-78-2(1H-Indazol-4-amine, 5-chloro-)
- 221681-75-0(6-Chloro-1H-indazol-5-amine)
- 1082041-33-5(4-Chloro-1H-indazol-5-amine)
- 221681-84-1(4-Chloro-1H-indazol-6-amine)
- 100959-52-2(4-Chloro-1H-indazol-7-amine)
- 112635-08-2(7-Chloro-1H-indazol-6-amine)
- 221681-89-6(7-Amino-5-chloro-1H-indazole)
- 885519-32-4(6-Chloro-1H-indazol-4-amine)